|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 27, 2017 ) Browse 102 market data Tables and 43 Figures spread through 184 Pages and in-depth TOC on "Molecular Biology Enzymes and Kits & Reagents Market"
http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
Early buyers will receive 10% customization on this report.
The overall molecular biology enzymes and kits & reagents market is dominated by Thermo Fisher Scientific, Inc. (U.S.) and Merck KGaA (Germany). These players jointly accounted for approximately 64% of the market in 2016. Other players having significant presence in this market include New England Biolabs, Inc. (U.S.), Promega (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-la Roche Ltd. (Switzerland), Takara Bio Inc. (Japan), QIAGEN N.V. (The Netherlands), and Becton, Dickinson and Company (U.S.).
Thermo Fisher Scientific, Inc. (U.S.) is among the leading players in the molecular biology enzymes and kits & reagents market. A wide product portfolio, high focus on increasing company presence in the emerging economies, and continuous launch of new and innovative products are contributing to the company’s dominance in this market. The company’s products are made available through its broad sales force and a global network of resellers and distributors. The company has approximately 12,000 sales and service personnel, including highly trained technical specialists.
Speak To Our Research Analysts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=164131709
The company has high focus on innovation through the launch of new products and acquisitions. During 2013 to 2016, the company made several acquisitions. For instance, in March 2016, Thermo Fisher acquired Affymetrix, Inc. (U.S.), a provider of innovative technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene levels.
The acquisition was aimed at integrating Affymetrix’s major product groups into Thermo Fisher Scientific’s existing businesses. Merck KGaA (Germany) is another major player in the molecular biology enzymes and kits & reagents market. The company has a well-established brand and has 72 production locations across 66 countries. To maintain its position in the market, the company is strategically focusing on collaborating with other players and end users, including Amoy Diagnostics Co., Ltd. (AmoyDx) (China) (2016), the European Molecular Biology Laboratory (EMBL) (Germany) (2016), and Biocartis NV (Belgium) (2016).
Read More | Get the Sample Pages:
http://www.marketsandmarkets.com/requestsample.asp?id=164131709
The company has also focused on expansion to meet market demands and enhance its capabilities. For example, Merck expanded its viral and gene production facility in California, U.S. in May 2016 to incorporate single -use equipment for commercial bulk drug and clinical production.
The other players in this market have implemented various strategies to expand their global footprints and increase their market shares. Major growth strategies followed by market players include new product launches, distribution agreements, collaborations, expansions, acquisitions, alliances, approvals, and partnerships. New product launches accounted for a major share followed by alliances/agreements/partnerships/collaborations, which accounted for the second-largest share of the total number of key growth strategies adopted by players in the molecular biology enzymes and kits & reagents market during 2013 to 2016. Approvals, CE markings, new service launches, new technology launches, market developments and grants are some of the other strategies adopted by players to achieve growth in the molecular biology enzymes and kits & reagents market.
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
